Check out the companies that make headlines before the bell:
Altimeter Growth (AGC) – The Southeast Asian Giant Grab will be released through a SPAC merger with Altimeter Growth, valued at nearly $ 40 billion. Grab says he intends to list the Nasdaq under the symbol “GRAB” after the transaction is completed. Altimeter shares increased by almost 9% in premarket trading.
Johnson & Johnson (JNJ) – Shares of the drug fell 2.8% in the premarket after the Food and Drug Administration said it was calling on states to discontinue J & J’s Covid-19 vaccine after six people in the US developed a rare disorder involving blood clots. The FDA said the recommendation was “out of an abundance of caution.” Moderna shares appeared with over 7% in the early trading of news.
FedEx (FDX) – The shares of the shipping company increased in premarket trading in connection with KeyBanc Capital Markets, which improved FedEx to “overweight”. The Wall Street firm also set a target price of $ 350 per share on FedEx. KeyBanc said FedEx can increase its volume, even with a return to in-person purchases.
JetBlue (JBLU), Spirit Airlines (SAVE) – The shares of the airlines appeared in the premarket trading after Susquehanna Financial Group updated JetBlue and Spirit Airlines to “positive”. “With a recovery in domestic air travel in the US underway, we want to own low-cost carriers,” he told the company’s customer analyst.
Booking Holdings (BKNG) – The tourism company won in premarket trading after Jefferies upgraded Booking to “buy” from “expect” a return of global travel. The former also raised its 12-month price target to $ 2,800 per share from $ 2,300 per share.
3M (MMM) – The shares of the manufacturing giant fell in the premarket after Deutsche Bank added a “catalyst call” sale to 3M. The Wall Street firm said the shares had curiously exceeded in recent weeks, despite Deutsche Bank’s expectations of a loss of future revenue.
NortonLifeLock (NLOK) – The security company fell in premarket trading after Bank of America initiated the shares with a rating of “underperformance” and a target price of $ 19 per share. “Last year’s increase in demand for COVID could relax in the coming quarters and the company could return to negative trends in churn and subscribers, having a negative impact on revenue growth,” the company said.
Honeywell (HON) – Honeywell shares rose in the pre-market after Deutsche Bank gave a catalytic rating “buy” on shares. The company said investors are not enthusiastic about Honeywell, despite the recovery.
Bristol-Myers Squibb (BMY) – The pharmaceutical company’s shares have risen in the premarket that Truist has upgraded Bristol-Myers Squibb to “buy” from the “hold” at a price of $ 74 per share. The Wall Street firm said it likes the Bristol-Myers Squibb drug pipeline.
Did you like this article?
For exclusive stock choices, investment ideas and CNBC’s global broadcast flow
Sign up for CNBC Pro
Start the free trial now